Wockhardt Limited
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Wockhardt Limited's yearly results (2023–2026), compared with Healthcare companies in India. Tap ? on any ratio for what it means.
What stands out
- Growth Efficiency Ratio: Sales grew 25% in 3 years; of every extra ₹100 of sales, ₹115 became extra profit. Higher than almost all Healthcare companies in India.
- Tangible Net Worth Ratio: Of every ₹100 of net worth, ₹42 is tangible; the rest is goodwill and other intangibles, often from buying other companies. Less tangible than 92% of Healthcare companies in India.
- Tangible Assets Ratio: Of every ₹100 the company owns, ₹67 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles. Less tangible than 91% of Healthcare companies in India.
Where ₹100 of sales goes
Latest year (Mar 2026). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
0.6×Over the last 3 years its own operating cash paid for 62% of its investment spending (capex); the rest came from other sources such as borrowing, cash reserves or new shares.
Lower than 77% of Healthcare companies in India.
Cash Locked Ratio
₹25For every ₹100 of sales, ₹25 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against ₹10 tied up three years earlier.
More money tied up than 51% of Healthcare companies in India.
Growth quality
Steadiness Ratio
3/3 · 3/3Sales and profit both grew in each of the last 3 years.
Steadier than 83% of Healthcare companies in India.
Growth Efficiency Ratio
₹115Sales grew 25% in 3 years; of every extra ₹100 of sales, ₹115 became extra profit.
Higher than almost all Healthcare companies in India.
Asset Productivity Ratio
+25% / +12%In 3 years sales changed by +25% while total assets changed by +12%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
0.6×Debt due within a year is covered 0.6 times by its yearly operating cash.
Lower than 65% of Healthcare companies in India.
Cash Cushion Ratio
−5%Debt, after subtracting cash, equals 5% of its market value (net debt).
Lower than 68% of Healthcare companies in India.
Tangible Assets Ratio
67%Of every ₹100 the company owns, ₹67 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 91% of Healthcare companies in India.
Tangible Net Worth Ratio
42%Of every ₹100 of net worth, ₹42 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
Less tangible than 92% of Healthcare companies in India.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (14)
Wockhardt Limited owes ₹0.39 for every ₹1 it owns. Wockhardt Limited returned to profit in the year to Mar 2026, after a loss the year before.
Compared with Healthcare companies in India · latest annual results Mar 2026.
P/E ratio
72.4Investors pay ₹72.4 for every ₹1 of Wockhardt Limited's yearly profit, higher than 82% of Healthcare companies in India.
P/B ratio
6.10The share price is 6.10 times Wockhardt Limited's book value per share, higher than 67% of Healthcare companies in India.
Market cap
₹30,150 CrThe total market value of all of Wockhardt Limited's shares at today's price (share price × number of shares), larger than 83% of Healthcare companies in India. PosiCap size class: Meso Cap.
Net worth (book value)
₹4,940 CrWhat Wockhardt Limited would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (31 Mar 2026).
Book value per share
₹304.01Net worth divided by the number of shares. The share price of ₹1,856 is 6.1 times this, which is the P/B above.
Return on equity (ROE)
8.5%Wockhardt Limited earned 8.5% on its shareholders' money over the last year, lower than 73% of Healthcare companies in India.
Owes vs Owns
0.39×Wockhardt Limited owes ₹0.39 for every ₹1 it owns (low), higher than 55% of Healthcare companies in India.
Dividend yield
NoneWockhardt Limited does not currently pay a dividend.
Revenue growth
+14%Revenue rose 14% in the year to Mar 2026, and grew 8% a year on average over 3 years.
Profit growth
Back to profitWockhardt Limited returned to profit in the year to Mar 2026, after a loss the year before.
Profit margin
6.4%Wockhardt Limited keeps ₹6 of every ₹100 of revenue as net profit.
Cash quality
1.8×Cash from Wockhardt Limited's business was 1.8× its reported profit in the year to Mar 2026 — its profit turned into cash.
Interest cover
1.9×Wockhardt Limited's operating profit covered its interest costs 1.9 times in the year to Mar 2026.
Cash vs debt
Net debtWockhardt Limited had ₹1,604 Cr more debt than cash (net debt) at Mar 2026.
Questions
What is Wockhardt Limited's P/E ratio?
Investors pay ₹72.4 for every ₹1 of Wockhardt Limited's yearly profit, higher than 82% of Healthcare companies in India.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Wockhardt Limited: ₹30,150 Cr ÷ ₹4,940 Cr (31 Mar 2026) = 6.1.
What is Wockhardt Limited's return on equity?
Wockhardt Limited earned 8.5% on its shareholders' money over the last year, lower than 73% of Healthcare companies in India.
How much does Wockhardt Limited owe compared with what it owns?
Wockhardt Limited owes ₹0.39 for every ₹1 it owns (low), higher than 55% of Healthcare companies in India.
Does Wockhardt Limited pay a dividend?
No. Wockhardt Limited does not currently pay a dividend.
Is Wockhardt Limited's revenue growing?
Revenue rose 14% in the year to Mar 2026, and grew 8% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.